Business Matters: Eclipsed by Catastrophe

Publication
Article
BioPharm InternationalBioPharm International-11-01-2001
Volume 14
Issue 11

by G. Steven Burrill at Burrill & Company Despite stimulating and positive news for biotech product approvals and high-value deals this quarter, market performance has been shaped by the terrorist attacks and their aftermath.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.